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Abstract: Whole-genome array Comparative Genomics Hybridization (aCGH) can be used to scan chromosomes for de-
letions and amplifications. Because of the increased accessibility of many commercial platforms, a lot of cancer research-
ers have used aCGH to study tumorigenesis or to predict clinical outcomes. Each data set is typically in several hundred 
thousands to one million rows of hybridization measurements. Thus, statistical analysis is a key to unlock the knowledge 
obtained from an aCGH study. We review several free and open-source packages in Bioconductor and provide example 
codes to run the analysis. The analysis of aCGH data provides insights of genomic abnormalities of cancers. 
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INTRODUCTION 
  DNA copy number alternations are critical events in the 
development and progression of cancers [1]. The array 
Comparative Genomics Hybridization (aCGH) provides a 
rapid screening of the whole genome for deletions and am-
plifications along chromosomes.  
  For instance, in our current studies, we use Sentrix Hu-
manHap650Y Genotyping BeadChips from Illumina. Tag 
SNPs on these chips interrogates >660,000 SNPs that can be 
used for whole-genome association studies and LOH/Copy 
number analyses. The Tag SNPs on the chip were selected 
from the HapMap release 21 data set. On average, the 650Y 
chips have one common SNP (MAF>0.05) every 5.3kb, 
6.2kb, and 5.4kb across the genome in the CEU, CHB+JPT, 
and YRI populations, respectively. The average 90
th percen-
tile gap between common SNPs (MAF>0.05) on the Human 
Hap650Y BeadChip is 12kb, 14kb and 12kb in the CEU, 
CHB+JPT, and YRI populations, respectively. As such, if we 
conservatively estimate that 10 SNP markers are necessary 
to detect an amplified or deleted region, we can use the 
Hap650Y BeadChip to detect chromosomal alterations at a 
resolution of 120-140 kb. 
  Briefly, aCGH has been widely used in cancer studies to 
detect genetic alterations, although aCGH usually cannot 
detect translocations and inversions. aCGH has been used for 
the following two goals: 
1) To Study Tumorigenesis 
  Genetic alterations, wherever measured by aCGH, can be 
used to find potential oncogenes (in amplified regions) and 
tumor suppressor genes (in deleted regions). For instance, 
five candidate tumor suppressor genes were discovered in a 
glioma study [2]. Moreover, the genetics alterations can be 
traced over time to monitor the progression of tumors.  
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2) To Predict Clinical Outcomes 
  Because tumorigenesis is driven by sequential acquisition 
of genetic alterations, it is highly likely that genomic aberra-
tion patterns can be used to predict tumor subtype, grade, or 
patient survival. Indeed, numerous studies have shown the 
potential of using aCGH in predicting clinical outcomes. For 
instance, a 190-gene signature was shown to predict astro-
cytic glioma with 92% accuracy [2]. However, these studies 
were usually retrospective rather than prospective. In addi-
tion, only one site was usually involved in the processing of 
the microarrays. Although the cross-institute and cross-
platform consistency has been shown with RNA profiling 
methods using microarrays [3], it is still unclear how robust 
the findings from aCGH are.  
aCGH 
  Earlier aCGH studies usually used home-made arrays 
with BAC clones. It was tedious, low resolution (because of 
the BAC clones), and hard to control the array-printing qual-
ity. Recent works extensively use commercial designs of 
oligo arrays from Agilent, Affymetrix and Illumina. It is 
interesting to note that Affymetrix and Illumina do not have 
any product lines of aCGH; aCGH was only considered as an 
“off-label” use of the SNP arrays. As such, the Affymetrix 
and Illumina platforms are able to genotype and to detect the 
chromosome aberrations at the same time. Because it is rela-
tively common for these SNP microarrays to have up to one 
million markers for the whole human genome, aCGH can be 
achieved at a very high resolution. A higher resolution can 
help one to see the boundaries of chromosomal alteration 
more precisely. A more elaborate introduction of aCGH can 
be found in a recent review paper [4].  
  After data preprocessing, regardless of the chosen plat-
form, the aCGH data can be reported as (x,y) pairs: x is the 
chromosome location; y is the normalized value proportional 
to the DNA copy number. Normally human cells contain two 
copies of each of the 22 non-sex chromosomes. Any devia-
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The objective of the data analysis is to identify the regions of 
gains and losses along the chromosome.  
EVALUATION OF aCGH SEGMENTATION ALGO-
RITHMS 
  Here we use a simulated data to illustrate how to run 
aCGH analysis using free and open-source packages in Bio-
conductor (Table 1). Bioconductor is a collection of statisti-
cal analysis packages for genomics data [5]. Here we se-
lected four popular aCGH analysis packages: aCGH [6], 
snapCGH [7], DNAcopy [8] and GLAD [9]. A brief descrip-
tion of the packages is shown in Table 1. 
 Fig.  (1) shows the computer codes to run each segmenta-
tion algorithm and one representative result. The simulated 
data (500 data points) has both varying segment lengths and 
varying amplitudes, as shown in Fig. (1). As the snapCGH 
package provides interface functions for the segmentation 
algorithms of different packages, we used these functions to 
run the simulation data. Note that the efficient design of the 
snapCGH package makes the programming as easy as one 
line of codes.  
  A visual examination of Fig. (1) suggests that the per-
formance of different algorithms is similar. To better evalu-
ate the difference in performance, we ran 100 simulated 
aCGH data for both varying segment amplitudes and fixed 
segment amplitudes, and then evaluate the difference be-
tween the estimated segmentation and true segmentation. 
Table 2 shows the summary of the evaluation results. We 
can see the HMM-based algorithms have better perform-
ances for the simulation data with fixed amplitudes. The ma-
jor reasons include HMM models is based on the global es-
timation and they try to convert the segment amplitudes into 
Table 1.  Free, Open-Source Bioconductor Packages for aCGH Analysis 
Package   Algorithm  Major Features 
aCGH  HomHMM  Homogeneous Hidden Markov Model 
snapCGH  BioHMM  Heterogeneous Hidden Markov Model (transition probability depends on the distance between adjacent clones) 
DNAcopy  CBS  Using circular binary segmentation 
GLAD  GLAD  Break points detection based on the Adaptive Weights Smoothing 
 
 
 
 
 
 
 
  (A) segInfo <- runHomHMM(CGH.simulated)   (B) segInfo <- runBioHMM(CGH. simulated) 
 
 
 
 
 
 
 
  (C) segInfo <- runDNAcopy(CGH.simulated)   (D) segInfo <- runGLAD(CGH.simulated) 
Fig. (1). Examples of the aCGH segmentation using simulated aCGH data. The black dots are real simulated aCGH data, the red line is the 
true segmentation and the green line is the estimated segmentation result. Four different algorithms are used; the corresponding codes are 
shown below each figure, where “<-“ indicates an assignment to a variable and “CGH.simulated” is the simulated aCGH data. 62    Current Genomics, 2009, Vol. 10, No. 1  Lin et al. 
very limited discrete transition states. As a result, when the 
data has varying segment amplitudes and some of them have 
short segment lengths, HMM models tend to have worse 
performance than other algorithms, like CBS and GLAD. On 
the other hand, the CBS and GLAD algorithms have consis-
tent performance for varying and fixed segment amplitudes, 
as shown in Table 2. Comparing HomHMM nad BioHMM, 
BioHMM has better overall performance, but it is at the ex-
pense of much longer running time. CBS comparatively has 
better performance than GLAD, but it is also slightly slower 
than GLAD. 
URGENT NEEDS FOR BENCHMARK DATA SETS 
  In the previous section, we have shown how to use dif-
ferent algorithms to analyze aCGH data. But which algo-
rithm shall one choose? Different algorithms are usually 
based on different statistical models with different assump-
tions, but which one is closer to the reality? These questions 
cannot be easily answered with simulated data only.  
  Currently, biological plausibility has been always used as 
a validation of the findings. For instance, the amplified or 
deleted regions were always cross-referenced with previous 
cytogenetic studies. However, boundaries from cytogenetic 
data are of much lower resolution than aCGH data; it cannot 
be used to judge different algorithms that call the boundary 
in the difference of 10 Kb. Moreover, biological plausibility 
is only a weak and indirect evidence to show the effective-
ness of an algorithm. 
  To move the data analysis forward and critically assess 
each method’s strength and weakness, we suggest that two 
types of benchmark data sets are urgently needed (Fig. 2). 
1) Spike-in Benchmarks 
  Similar to the Affymetrix Latin Square Spike-in data of 
mRNAs, several pieces of chromosomes can be spiked into a 
sample in permutations. Because of the truth is known, the 
algorithms can be explicitly tested for their performance on 
false positive and false negative rates.  
2) Titration Benchmarks 
  A titration benchmark data is especially important for the 
study of tumor genetic alterations where the sample is more 
likely to be a mixture of normal and abnormal cell types. 
First, tumors are known to be genetically heterogeneous, 
where certain clones may harbor amplification and deletions 
at certain regions and others do not. Second, the samples 
measured usually contain adjacent normal cells. Although 
laser microdissection or fluorescence in situ hybridization 
offers a workaround, it is critical to understand how an ana-
lytical system is capable to handle admixtures. A titration 
experiment in Fig. (2) (B) using normal and tumor cell lines 
can facilitate the evaluation.  
RT-PCR VALIDATION OF THE HIGH-THROUGH- 
PUT RESULTS 
  Similar to microarray-based RNA profiling, the results 
from aCGH study usually need to be cross-validated using 
another platform, for instance, conventional cytogenetics, 
FISH, or RT-PCR.  
  For RT-PCR based validation, a reference gene should be 
chosen to normalize the results. Generally, the reference 
gene should not have copy number variation in normal popu-
lations. Conceptually, it is very similar to “housekeeping” 
Table 2.  Evaluation of aCGH Segmentation Algorithm Using Simulated Data 
 MeanDiff1  SDDiff1  MeanDiff2  SDDiff2  Time (Seconds) 
HomHMM  13.12 4.19 23.78 7.50  11.2 
BioHMM  6.84 3.77  20.61 7.02 896.1 
CBS 17.75 4.04 17.38 4.39  66.7 
GLAD  19.94 4.25 19.63 4.39  29.0 
“Diff1” represents the difference between the estimated and true segmentation for the fixed segmentation amplitudes, and “Diff2” represents the one for varying segmentation ampli-
tudes, as shown in Fig. (1). “Mean” represents the average of the difference, and “SD” represents the standard deviation. “Time” is the total time of processing 100 simulated aCGH 
data. 
 
 
 
 
 
 
Fig. (2). Data sets from necessary benchmark experiments to evaluate aCGH algorithms. (A) Spike-in and (B) Titration.  Using Free and Open-Source Bioconductor Packages to Analyze aCGH Data  Current Genomics, 2009, Vol. 10, No. 1    63 
gene used for the RT-CPR study of mRNAs. For instance, 
the gene of RNA-specific adenosine deaminase (ADAR) was 
used as a reference gene in a glioma study [2] to validate the 
chromosomal loss or gain.  
REFERENCES 
[1]  Lengauer, C., Kinzler, K.W., Vogelstein, B. Genetic instabilities in 
human cancers. Nature 1998, 396: 643-649. 
[2]  Bredel, M., Bredel, C., Juric, D., Harsh, G.R., Vogel, H., Recht, 
L.D., Sikic, B.I. High-resolution genome-wide mapping of genetic 
alterations in human glial brain tumors. Cancer Res.  2005,  65: 
4088-4096. 
[3]  Shi, L., Tong, W., Fang, H., Scherf, U., Han, J., Puri, R.K., Frueh, 
F.W., Goodsaid, F.M., Guo, L., Su, Z., Han, T., Fuscoe, J.C., Xu, 
Z.A., Patterson, T.A., Hong, H., Xie, Q., Perkins, R.G., Chen, J.J., 
Casciano, D.A. Cross-platform comparability of microarray tech-
nology: intra-platform consistency and appropriate data analysis 
procedures are essential. BMC Bioinformatics  2005,  6(Suppl  2): 
S12. 
[4]  Pinkel, D., Albertson, D.G. Array comparative genomic hybridiza-
tion and its applications in cancer. Nat. Genet. 2005, 37(Suppl): 
S11-17. 
[5]  Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, 
M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., Hornik, K., 
Hothorn, T., Huber, W., Iacus, S., Irizarry, R., Leisch, F., Li, C., 
Maechler, M., Rossini, A.J., Sawitzki, G., Smith, C., Smyth, G., 
Tierney, L., Yang, J.Y., Zhang, J. Bioconductor: open software de-
velopment for computational biology and bioinformatics. Genome 
Biol. 2004, 5: R80. 
[6]  Fridlyand, J., Snijders, A.M., Pinkel, D., Albertson, D.G., Jain, 
A.N. Hidden Markov models approach to the analysis of array 
CGH data. J. Multivar. Anal. 2004, 90: 132-153. 
[7]  Marioni, J.C., Thorne, N.P., Tavare, S. BioHMM: a heterogeneous 
hidden Markov model for segmenting array CGH data. Bioinfor-
matics 2006, 22: 1144-1146. 
[8]  Olshen, A.B., Venkatraman, E.S., Lucito, R., Wigler, M. Circular 
binary segmentation for the analysis of array-based DNA copy 
number data. Biostatistics 2004, 5: 557-572. 
[9]  Hupe, P., Stransky, N., Thiery, J.P., Radvanyi, F., Barillot, E. 
Analysis of array CGH data: from signal ratio to gain and loss of 
DNA regions. Bioinformatics 2004, 20: 3413-3422. 
 
 